Geographic Availability Not available in AR, LA, MS, NM Clinical Oversight and Safety Licensed providers review all prescriptions for safety and accuracy
Tirzepatide is a dual incretin receptor agonist studied for its interaction with: Within metabolic research environments, Tirzepatide is frequently examined for: Metabolic signalling behaviour Appetite-regulation pathways Glucose-response modelling Incretin hormone analysis Body-composition research Advanced metabolic pathway observation Due to its dual-receptor activity, Tirzepatide has become a major focus in peptide and metabolic science research protocols
The Wegovy Savings Card will bring your costs down to $499/month if you dont have insurance and will save you up to $225 beyond what your insurance is covering if you do have commercial insurance
A $75 consult fee unlocks the medical visit, and Pomegranate credits that $75 back toward your medication
Interestingly, the combination of GLP-1 and GIP on glucagon secretion is reported either to offset 31,32,33 or to decrease glucagon levels 34